- 1、本文档共13页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
WCLC2016肺癌—奥希替尼AURA3研究结果公布 图文
Presented by VA Papadimitrakopoulou at the World Conference on Lung Cancer 2016
Plenary Session: PL03 Presidential Symposium (abstract PL03.03)
Vassiliki A Papadimitrakopoulou1, Yi-Long Wu2, Myung-Ju Ahn3, Suresh S Ramalingam4, Marina Chiara Garassino5, Hye Ryun Kim6, Frances A Shepherd7, Hiroaki Akamatsu8, Willemijn SME Theelen9, Chee Khoon Lee10, Martin Sebastian11, Alison Templeton12, Marcelo Marotti12, Serban Ghiorghiu12, Tony Mok13
Randomised Phase III study of osimertinib vs platinum-pemetrexed for EGFR T790M-positive advanced NSCLC (AURA3)
1Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Guangdong Lung Cancer Institute, Guangdong General Hospital Guangdong Academy of Medical Sciences, Guangzhou, China; 3Samsung Medical Center, Seoul, Republic of Korea; 4Emory University, Winship Cancer Institute, Atlanta, GA, USA; 5Medical Oncology Department, Thoracic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 6Department of Internal Medicine, Division of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea; 7Princess Margaret Cancer Centre, Toronto, Canada; 8Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan; 9Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; 10St George Hospital, Clinical Research Unit, Division of Cancer Services, Pitney Clinical Sciences Building, Kogarah, New South Wales, Australia; 11University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; 12AstraZeneca, Cambridge, UK; 13Key Laboratory of South China, Department of Clinical Oncology, The Chinese University of Hong Kong, Sha Tin, Hong Kong
Disclosures
Vassiliki A Papadimitrakopoulou: consultancy for AstraZeneca, ARIAD, BMS, Genentech, Biothera, Janssen, Clovis, Merck, Eli Lilly; grants / research support from AstraZeneca, Genentech, Merck, BMS, Novartis, Janssen, AC
您可能关注的文档
- S版小语二年级下册《找不到快乐的波斯猫》.ppt
- syngo Somatom CT简易操作手册.ppt
- T-mac篮球生涯英文介绍.ppt
- T206 SAP OneService- 拓展与统一 - 全渠道零售数字转型之路.pptx
- TD LTE基站智能天线性能分析.doc
- TD-SCDMA业务解决方案.doc
- The differences between Chinese food culture and western’s.ppt
- The Fundamental Counting Principle - Salisbury … 13641:基本的计算原则——索尔兹伯里…… 13641.docx
- The Role of Direct Agreements in a PPP Project:直接协议PPP项目中的作用.ppt
- tksisu计算机系统结构小抄.doc
文档评论(0)